Wellington Management Group LLP Celldex Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$529 Billion
Q2 2025

A detailed history of Wellington Management Group LLP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 5,232,326 shares of CLDX stock, worth $125 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,232,326

Previous 8,354,151 37.37%

Holding current value

$125 Million

Previous $152 Million 29.78%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$15.13 - $21.65 $47.2 Million - $67.6 Million	-3,121,825 Reduced 37.37%	5,232,326 $106 Million
Q1 2025 May 13, 2025	BUY	$18.15 - $27.6 $152 Million - $231 Million	8,354,151 New	8,354,151 $152 Million
Q4 2024 Feb 12, 2025	SELL	$23.31 - $32.4 $6.24 Million - $8.68 Million	-267,766 Reduced 2.9%	8,975,833 $227 Million
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $37.4 Million - $52 Million	1,167,659 Added 14.46%	9,243,599 $314 Million
Q2 2024 Aug 13, 2024	BUY	$32.76 - $42.56 $14 Million - $18.2 Million	428,483 Added 5.6%	8,075,940 $299 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $269 Million - $397 Million	7,647,457 New	7,647,457 $321 Million
Q4 2023 Feb 12, 2024	BUY	$22.61 - $40.65 $146 Million - $263 Million	6,476,561 New	6,476,561 $257 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $7.65 Million - $11.3 Million	300,406 Added 5.85%	5,431,833 $149 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $28.8 Million - $36.4 Million	949,816 Added 22.71%	5,131,427 $174 Million
Q1 2023 May 12, 2023	SELL	$34.78 - $47.43 $16.2 Million - $22.1 Million	-466,301 Reduced 10.03%	4,181,611 $150 Million
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $43.5 Million - $71.1 Million	1,567,179 Added 50.87%	4,647,912 $207 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $5.46 Million - $9.03 Million	240,350 Added 8.46%	3,080,733 $86.6 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $14.1 Million - $25.7 Million	-689,457 Reduced 19.53%	2,840,383 $76.6 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $37.1 Million - $52.8 Million	1,343,864 Added 61.48%	3,529,840 $120 Million
Q4 2021 Feb 11, 2022	BUY	$35.68 - $56.27 $200,664 - $316,462	5,624 Added 0.26%	2,185,976 $84.5 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $6.29 Million - $12.2 Million	217,353 Added 11.07%	2,180,352 $118 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $1.54 Million - $2.63 Million	74,263 Added 3.93%	1,962,999 $65.6 Million
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $29.1 Million - $53.7 Million	1,794,536 Added 1905.03%	1,888,736 $38.9 Million
Q4 2020 Feb 12, 2021	BUY	$14.99 - $22.75 $1.41 Million - $2.14 Million	94,200 New	94,200 $1.65 Million

Others Institutions Holding CLDX

# of Institutions

196

Shares Held

66.8M

Call Options Held

208K

Put Options Held

345K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Celldex Therapeutics, Inc. Transaction History